SCHEMBL29629099

SCHEMBL29629099

CCN(C/C=C\c1ccc(C2CCCCC2)c(Cl)c1)C1CCCCC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 1.00
TMEM97 Q5BJF2 1/20 1.00
EBP Q15125 1/20 1.00
KDM4E B2RXH2 1/20 0.40
TRPM8 Q7Z2W7 3/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
TSHR P16473 1/20 0.34
KCNH2 Q12809 2/20 0.32
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31
HTR2B P41595 1/20 0.31
ALDH1A1 P00352 1/20 0.30
CEL P19835 1/20 0.30
NOS3 P29474 1/20 0.30
NOS1 P29475 1/20 0.30
NOS2 P35228 1/20 0.30
NSD2 O96028 1/20 0.30
NSD1 Q96L73 1/20 0.30
NSD3 Q9BZ95 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29412724 1.00 SIGMAR1 (1.00) SIGMAR1TMEM97EBPKDM4ETRPM8
SCHEMBL6648743 1.00 SIGMAR1 (1.00) SIGMAR1TMEM97EBPKDM4ETRPM8
SCHEMBL6652640 1.00 SIGMAR1 (1.00) SIGMAR1TMEM97EBPKDM4ETRPM8
SCHEMBL6648742 1.00 SIGMAR1 (1.00) SIGMAR1TMEM97EBPKDM4ETRPM8
Hydrochloric Acid SCHEMBL7285300 0.99 SIGMAR1 (0.98) SIGMAR1TMEM97EBPKDM4ETRPM8
Hydrochloric Acid SCHEMBL7285292 0.99 SIGMAR1 (0.98) SIGMAR1TMEM97EBPKDM4ETRPM8
Hydrochloric Acid SCHEMBL29360056 0.99 SIGMAR1 (0.98) SIGMAR1TMEM97EBPKDM4ETRPM8
Hydrochloric Acid SCHEMBL7285285 0.99 SIGMAR1 (0.98) SIGMAR1TMEM97EBPKDM4ETRPM8
Hydrochloric Acid SCHEMBL1650862 0.98 SIGMAR1 (0.95) SIGMAR1TMEM97EBPKDM4ETRPM8
SCHEMBL2131382 0.88 SIGMAR1 (0.79) SIGMAR1TMEM97EBPKDM4ETRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260062374-A1 PROCESS FOR THE PREPARATION OF A BENZENE DERIVATIVE MELETIOS THERAPEUTICS (FR) 2026-03-05 US disclosed
WO-2025068686-A1 TREATMENT FOR BATTEN DISEASE THE ROYAL VETERINARY COLLEGE (GB) 2025-04-03 WO disclosed
CN-114652735-A Compounds and methods for promoting myelination 凯斯西储大学 2022-06-24 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062374-A1 PROCESS FOR THE PREPARATION OF A BENZENE DERIVATIVE BRDT, CYP3A7, TP53 SIGMAR1 39/4885TMEM97 7/4885EBP 249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.